Merck & Co. Inc. buy Royal Bank of Canada
Start price
30.03.26
/
50%
€102.80
Target price
30.03.27
€123.30
Performance (%)
2.06%
Price
05.06.26
€104.92
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 2.06%. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 3.105% | 3.105% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€105.40
25.02.26
25.02.26
€120.47
25.02.27
25.02.27
-0.46%
05.06.26
05.06.26
